Catalio Capital Management, LP
Q2 2026 13F filing
Updated 27 days ago39 disclosed positions worth $532.1M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AVLN AVALYN PHARMACEUTICALS INC | $55.2M | 1.68M | 10.37% | — |
| 2 | J JNJ JOHNSON & JOHNSON | $35.3M | 138.9K | 6.63% | — |
| 3 | G GILD GILEAD SCIENCES INC | $34M | 269.3K | 6.39% | — |
| 4 | B BBIO BRIDGEBIO PHARMA INC | $33.9M | 455.0K | 6.37% | — |
| 5 | S SNDX SYNDAX PHARMACEUTICALS INC | $26.6M | 1.22M | 4.99% | — |
| 6 | D DFTX DEFINIUM THERAPEUTICS INC | $26.5M | 562.7K | 4.97% | — |
| 7 | C CELG-RI BRISTOL-MYERS SQUIBB CO | $23.8M | 413.0K | 4.47% | — |
| 8 | P PBLS PARABILIS MEDICINES INC | $22.6M | 824.0K | 4.24% | — |
| 9 | N NTRA NATERA INC | $22.3M | 82.2K | 4.19% | — |
| 10 | I INCY INCYTE CORP | $21.7M | 191.6K | 4.08% | — |
| 11 | S SEPN SEPTERNA INC | $18M | 536.2K | 3.37% | — |
| 12 | M MLYS MINERALYS THERAPEUTICS INC | $17.5M | 648.7K | 3.29% | — |
| 13 | H HTFL HEARTFLOW INC | $17.1M | 583.1K | 3.21% | — |
| 14 | C CRVS CORVUS PHARMACEUTICALS INC | $16.1M | 1.08M | 3.03% | — |
| 15 | G GPCR STRUCTURE THERAPEUTICS INC | $14.8M | 276.6K | 2.79% | — |
| 16 | P PB PROTAGONIST THERAPEUTICS INC | $13.1M | 106.8K | 2.46% | — |
| 17 | I IRON DISC MEDICINE INC | $11.7M | 159.4K | 2.19% | — |
| 18 | E EW EDWARDS LIFESCIENCES CORP | $11.3M | 124.8K | 2.12% | — |
| 19 | A AXSM AXSOME THERAPEUTICS INC. | $10.6M | 43.2K | 1.99% | — |
| 20 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $10.6M | 316.3K | 1.98% | — |
| 21 | K KLRA KAILERA THERAPEUTICS INC | $10.3M | 468.8K | 1.94% | — |
| 22 | K KPTI KARYOPHARM THERAPEUTICS INC | $9.2M | 940.9K | 1.73% | — |
| 23 | O ODTX ODYSSEY THERAPEUTICS INC | $8.6M | 457.8K | 1.61% | — |
| 24 | A ASND ASCENDIS PHARMA A/S | $8.5M | 31.8K | 1.59% | — |
| 25 | ? N/A KARDIGAN INC | $7.5M | 312.5K | 1.40% | — |
| 26 | E ELDN ELEDON PHARMACEUTICALS INC | $6.7M | 1.70M | 1.26% | — |
| 27 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $6.3M | 471.3K | 1.18% | — |
| 28 | M MANE VERADERMICS INC | $5.6M | 45.9K | 1.06% | — |
| 29 | D DYN DYNE THERAPEUTICS INC | $5.4M | 244.9K | 1.02% | — |
| 30 | G GUTS FRACTYL HEALTH INC | $4.9M | 6.17M | 0.92% | — |
| 31 | I IMCR IMMUNOCORE HLDGS PLC | $4.7M | 148.0K | 0.88% | — |
| 32 | D DNTH DIANTHUS THERAPEUTICS INC | $3.2M | 32.9K | 0.60% | — |
| 33 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $2.4M | 318.4K | 0.46% | — |
| 34 | T TARA PROTARA THERAPEUTICS INC | $2M | 520.1K | 0.37% | — |
| 35 | ? N/A HYPERFINE INC | $1.8M | 1.32M | 0.33% | — |
| 36 | A ATAI ATAIBECKLEY INC | $1M | 196.9K | 0.20% | — |
| 37 | M MGX METAGENOMI THERAPEUTICS INC | $630K | 529.0K | 0.12% | — |
| 38 | ? N/A OUTSET MED INC | $511K | 118.3K | 0.10% | — |
| 39 | F FTH FAETH THERAPEUTICS INC | $368K | 14.7K | 0.07% | — |